Why No Rules, Rules at Netflix
Michelle Martin speaks with co-author of the book No Rules Rules, Erin Meyer to understand how the lack of rules at Netflix enables a corporate culture where creativity and high-performance can thrive...
27 Okt 202020min
Company in the Spotlight - Twilio
Twilio's revenue vaulted 52% to $447.9 million from $295.1 million a year ago and its fiscal 3rd quarter revenue outdid estimates. Michelle Martin speaks with Glenn Weinstein, Chief Customer Officer ...
27 Okt 202012min
Sell off in US stocks, China to sanction Boeing over US arms sale to Taiwan, AstraZeneca breakthrough, Ant Group to list and Dunkin Donuts looking to go private
On Market View, Michelle Martin and Ryan Huang discuss the top few reasons for the sell-off in US stocks - COVID-19 cases on the rise and ongoing stimulus negotiations, China to sanction Boeing and ot...
27 Okt 20209min
The Tech Divide - How will Digitalization, Digital Currencies, Payment Systems set a new business order?
Michelle Martin speaks to Krishna Ramachandra, Managing Director, Duane Morris and Selvam LLC and Senior Advisor to the Global Blockchain Foundation and Chairman of the Helix Initiative to discuss the...
26 Okt 202024min
Upcoming FAANG earning expectations, Google, Facebook and Twitter to testify in Congress, Mr DIY's IPO
Michelle Martin speaks to Ryan Huang to discuss expectations for the upcoming FAANG earnings, the chiefs of Google, Facebook and Twitter to appear before the US Congress to discuss the rules that gove...
26 Okt 202012min
Tracking the final US Presidential Debate live
Michelle Martin speaks to Jeffrey Halley, Senior Market Analyst at OANDA to break down possible investor reaction to the debate and key topics from COVID-19 to foreign policy to impact on America's ec...
23 Okt 202019min
Pushing the boundaries for organic food
Michelle Martin speaks to Seng Yee Tai, Executive Director of Zenxin Organic Food to discuss organic foods, maintaining the price point to make organic food accessible and bringing the business into t...
23 Okt 202015min
US FDA approves remdesivir for hospitalised COVID-19 patients, Goldman's fine over 1MDB largest ever in a corruption case, China's feeder ETFs
Michelle Martin and Ryan Huang discuss Gilead's remdesivir's approval by the US FDA for hospitalised COVID-19 patients, the US economy and COVID-19 in early minutes of the final presidential debate, G...
23 Okt 202011min
